301 related articles for article (PubMed ID: 28063866)
1. Chemotherapy-Induced Neuropathy in Cancer Survivors.
Miaskowski C; Mastick J; Paul SM; Topp K; Smoot B; Abrams G; Chen LM; Kober KM; Conley YP; Chesney M; Bolla K; Mausisa G; Mazor M; Wong M; Schumacher M; Levine JD
J Pain Symptom Manage; 2017 Aug; 54(2):204-218.e2. PubMed ID: 28063866
[TBL] [Abstract][Full Text] [Related]
2. Age-related differences in patient-reported and objective measures of chemotherapy-induced peripheral neuropathy among cancer survivors.
Wong ML; Cooper BA; Paul SM; Abrams G; Topp K; Kober KM; Chesney MA; Mazor M; Schumacher MA; Conley YP; Levine JD; Miaskowski C
Support Care Cancer; 2019 Oct; 27(10):3905-3912. PubMed ID: 30770977
[TBL] [Abstract][Full Text] [Related]
3. Hearing loss and tinnitus in survivors with chemotherapy-induced neuropathy.
Miaskowski C; Paul SM; Mastick J; Schumacher M; Conley YP; Smoot B; Abrams G; Kober KM; Cheung S; Henderson-Sabes J; Chesney M; Mazor M; Wallhagen M; Levine JD
Eur J Oncol Nurs; 2018 Feb; 32():1-11. PubMed ID: 29353626
[TBL] [Abstract][Full Text] [Related]
4. Associations Between Perceived Stress and Chemotherapy-Induced Peripheral Neuropathy and Otoxicity in Adult Cancer Survivors.
Miaskowski C; Paul SM; Mastick J; Abrams G; Topp K; Smoot B; Kober KM; Chesney M; Mazor M; Mausisa G; Schumacher M; Conley YP; Sabes JH; Cheung S; Wallhagen M; Levine JD
J Pain Symptom Manage; 2018 Jul; 56(1):88-97. PubMed ID: 29524582
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic Characterization of Paclitaxel-Induced Peripheral Neuropathy in Cancer Survivors.
Kober KM; Mazor M; Abrams G; Olshen A; Conley YP; Hammer M; Schumacher M; Chesney M; Smoot B; Mastick J; Paul SM; Levine JD; Miaskowski C
J Pain Symptom Manage; 2018 Dec; 56(6):908-919.e3. PubMed ID: 30172061
[TBL] [Abstract][Full Text] [Related]
6. Similarities in the Neuropathy Phenotype of Cancer Survivors Who Received Different Classes of Chemotherapy Drugs.
Miaskowski C; Levine JD; Paul SM; Cooper B; Abrams G; Topp K; Cheung S; Henderson-Sabes J; Conley YP; Snowberg K; Alfaro E; Quinn M; Kober KM
J Pain; 2022 Sep; 23(9):1604-1615. PubMed ID: 35533976
[TBL] [Abstract][Full Text] [Related]
7. Impact of chemotherapy-induced neurotoxicities on adult cancer survivors' symptom burden and quality of life.
Miaskowski C; Mastick J; Paul SM; Abrams G; Cheung S; Sabes JH; Kober KM; Schumacher M; Conley YP; Topp K; Smoot B; Mausisa G; Mazor M; Wallhagen M; Levine JD
J Cancer Surviv; 2018 Apr; 12(2):234-245. PubMed ID: 29159795
[TBL] [Abstract][Full Text] [Related]
8. Deleterious Effects of Higher Body Mass Index on Subjective and Objective Measures of Chemotherapy-Induced Peripheral Neuropathy in Cancer Survivors.
Petrovchich I; Kober KM; Wagner L; Paul SM; Abrams G; Chesney MA; Topp K; Smoot B; Schumacher M; Conley YP; Hammer M; Levine JD; Miaskowski C
J Pain Symptom Manage; 2019 Aug; 58(2):252-263. PubMed ID: 31047960
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy-Induced Peripheral Neuropathy in Long-term Survivors of Childhood Cancer: Clinical, Neurophysiological, Functional, and Patient-Reported Outcomes.
Kandula T; Farrar MA; Cohn RJ; Mizrahi D; Carey K; Johnston K; Kiernan MC; Krishnan AV; Park SB
JAMA Neurol; 2018 Aug; 75(8):980-988. PubMed ID: 29799906
[TBL] [Abstract][Full Text] [Related]
10. Association Between Physical Activity Levels and Chemotherapy-Induced Peripheral Neuropathy Severity in Cancer Survivors.
Wilcoxon A; Kober KM; Viele C; Topp K; Smoot B; Abrams G; Chesney M; Paul SM; Conley YP; Levine JD; Miaskowski C
Oncol Nurs Forum; 2020 Nov; 47(6):703-719. PubMed ID: 33063789
[TBL] [Abstract][Full Text] [Related]
11. Expression of mitochondrial dysfunction-related genes and pathways in paclitaxel-induced peripheral neuropathy in breast cancer survivors.
Kober KM; Olshen A; Conley YP; Schumacher M; Topp K; Smoot B; Mazor M; Chesney M; Hammer M; Paul SM; Levine JD; Miaskowski C
Mol Pain; 2018; 14():1744806918816462. PubMed ID: 30426838
[TBL] [Abstract][Full Text] [Related]
12. Long-term peripheral neuropathy symptoms in breast cancer survivors.
Mustafa Ali M; Moeller M; Rybicki L; Moore HCF
Breast Cancer Res Treat; 2017 Nov; 166(2):519-526. PubMed ID: 28791499
[TBL] [Abstract][Full Text] [Related]
13. The reliability and validity of a modified total neuropathy score-reduced and neuropathic pain severity items when used to measure chemotherapy-induced peripheral neuropathy in patients receiving taxanes and platinums.
Smith EM; Cohen JA; Pett MA; Beck SL
Cancer Nurs; 2010; 33(3):173-83. PubMed ID: 20357656
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the effects of sensorimotor exercise on physical and psychological parameters in breast cancer patients undergoing neurotoxic chemotherapy.
Vollmers PL; Mundhenke C; Maass N; Bauerschlag D; Kratzenstein S; Röcken C; Schmidt T
J Cancer Res Clin Oncol; 2018 Sep; 144(9):1785-1792. PubMed ID: 29943097
[TBL] [Abstract][Full Text] [Related]
15. Randomized controlled trial of neurofeedback on chemotherapy-induced peripheral neuropathy: A pilot study.
Prinsloo S; Novy D; Driver L; Lyle R; Ramondetta L; Eng C; McQuade J; Lopez G; Cohen L
Cancer; 2017 Jun; 123(11):1989-1997. PubMed ID: 28257146
[TBL] [Abstract][Full Text] [Related]
16. [Peripheral neuropathy as a side effect of chemotherapy and targeted therapy].
Gießen-Jung C; von Baumgarten L
Dtsch Med Wochenschr; 2018 Jul; 113(13):970-978. PubMed ID: 29972842
[TBL] [Abstract][Full Text] [Related]
17. Falls, Functioning, and Disability Among Women With Persistent Symptoms of Chemotherapy-Induced Peripheral Neuropathy.
Winters-Stone KM; Horak F; Jacobs PG; Trubowitz P; Dieckmann NF; Stoyles S; Faithfull S
J Clin Oncol; 2017 Aug; 35(23):2604-2612. PubMed ID: 28586243
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy-induced neuropathy and its association with quality of life among 2- to 11-year colorectal cancer survivors: results from the population-based PROFILES registry.
Mols F; Beijers T; Lemmens V; van den Hurk CJ; Vreugdenhil G; van de Poll-Franse LV
J Clin Oncol; 2013 Jul; 31(21):2699-707. PubMed ID: 23775951
[TBL] [Abstract][Full Text] [Related]
19. Assessment of chemotherapy-induced peripheral neuropathy using the LDIFLARE technique: a novel technique to detect neural small fiber dysfunction.
Sharma S; Venkitaraman R; Vas PR; Rayman G
Brain Behav; 2015 Jul; 5(7):e00354. PubMed ID: 26221574
[TBL] [Abstract][Full Text] [Related]
20. Referred symptom from myofascial pain syndrome: One of the most important causes of sensory disturbance in breast cancer patients using taxanes.
Ko EJ; Jeon JY; Kim W; Hong JY; Yi YG
Eur J Cancer Care (Engl); 2017 Nov; 26(6):. PubMed ID: 28004441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
